Abstract
Study objectives Axillary lymph node metastasis (ALNM) from lung cancer is rare. Its prognosis and effective treatments remain unknown. To evaluate clinicopatholgical characteristics of such lung cancer patients, we performed a retrospective study of them, who had ALNM at the time of initial presentation or developed ALNM in their clinical courses. Methods We reviewed the medical records and pathological reports of all patients at our division who had a diagnosis of primary lung cancer from January 1985 through August 2007. Results Ten (0.75%) of 1,340 patients had ALNM. In eight of them, ALNM was detected at the time of initial diagnosis, and two patients developed ALNM in their clinical courses. Lymphatic metastasis to mediastinum was evident in all patients. Supraclavicular and cervical lymph nodes were involved in five and three patients, respectively. One patient had direct chest wall invasion from the lung. Three patients had distant metastases other than axillary or cervical lymph nodes. Four patients received systemic chemotherapy, and another four patients received palliative chest irradiation or supportive care because of their poor performance status. Median survival time of 8 patients who were diagnosed as having ALNMs at initial presentation was 7 months. Conclusions The most likely mechanism for axillary node involvement is intercostal lymphatics via spread from mediastinal lymph node metastasis. Routine palpation of the axillae is recommended if chest wall invasion, mediastinal and/or supraclavicular lymph nodes are found either at initial presentation or at follow-up of patients.
Similar content being viewed by others
References
Ochsner A, DeBakey M. Significance of metastasis in primary carcinoma of the lungs: two cases with unusual site of metastasis. J Thorac Surg. 1942;11:357–87.
Marcantonio DR, Libshitz HI. Axillary lymph node metastases of bronchogenic carcinoma. Cancer. 1995;76:803–6. doi :10.1002/1097-0142(19950901)76:5<803::AID-CNCR2820760514>3.0.CO;2-0.
Riquet M, Le Pimpec-Barthes F, Danel C. Axillary lymph node metastases from bronchogenic carcinoma. Ann Thorac Surg. 1998;66:920–2. doi:10.1016/S0003-4975(98)00556-6.
Seely JM, Mayo JR, Miller RR, Müller NL. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology. 1993;186:129–32.
Protopapas Z, Westcott JL. Transthoracic needle biopsy of mediastinal lymph nodes for staging lung and other cancers. Radiology.. 1996;199:489–96.
World Health Organizations. Histological typing of lung and pleural tumours. 3rd ed. Geneva: International Histological Classification of Tumours; 1999.
Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–7. doi:10.1378/chest.111.6.1710.
Spencer H. Pathology of the lung, vol. 2. 4th ed. Oxford: Pergamon; 1995
Onuigbo WI. Contralateral cervical node metastases in lung cancer. Thorax. 1962;17:201–4.
Baird JA. The pathways of lymphatic spread of carcinoma of the lung. Br J Surg. 1965;52:868–75. doi:10.1002/bjs.1800521109.
Riquet M. Anatomic basis of lymphatic spread from carcinoma of the lung to the mediastinum: surgical and prognosis implications. Surg Radiol Anat. 1993;15:273–7.
Riquet M, Etienne G, Debesse B, Chrétien J. Direct metastases of abdominal lymph nodes in bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1990;100:143–4.
LePimpec Barthes F, Riquet M, Hartl D, Hubsch JP, Hidden G. Cervical venous anastomoses of pulmonary lymphatic vessels. Surg Radiol Anat. 1997;19:53–5.
Rouvière H. Anatomie des lymphatiques de l’homme Masson, Paris; 1932.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Satoh, H., Ishikawa, H., Kagohashi, K. et al. Axillary lymph node metastasis in lung cancer. Med Oncol 26, 147–150 (2009). https://doi.org/10.1007/s12032-008-9097-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9097-4